돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 35260생성일: 2026년 10월 24일

Triethylamine → N-ethyl-N-cyclohexyl-5-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)valeramide

https://huagongshe.com/ko/reaction/35260

반응식

참여 물질

역할이름HCID투입량
반응물TriethylamineHCID 8471—
반응물N-Ethyl cyclohexylamineHCID 21609—
반응물Isobutyl chloroformateHCID 62365—
반응물5-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)valeric acidHCID 13203402—
용매TetrahydrofuranHCID 8028—
생성물N-ethyl-N-cyclohexyl-5-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)valeramideHCID 1320339772.6%

반응 단계

5-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)valeric acid (2.5 g) is dissolved in tetrahydrofuran (50 ml), and thereto is added triethylamine (1.1 g). To the mixture is added dropwise with stirring isobutyl chloroformate (1.5 g) under ice-cooling, and the mixture is stirred at room temperature for 30 minutes. To the mixture is added dropwise with stirring N-ethyl-cyclohexylamine (1.5 g) at room temperature, and the mixture is further stirred for 2 hours. After distilling off tetrahydrofuran, water is added to the residue, and the mixture is extracted with chloroform. The chloroform layer is washed with an aqueous saturated sodium chloride solution and dried over magnesium sulfate. Chloroform is distilled off, and the resulting residue is subjected to column chromatography (Kieselgel 60, made by Merck & Co., eluting solvent, chloroform) to isolate N-ethyl-N-cyclohexyl-5-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)valeramide (2.6 g), white crystalline powder (ether), m.p. 92°-95° C.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US04766120
출처 데이터셋uspto-grants-1988_08
ORD IDord-25fc57d6c3534e629f1814f0d825248e
출처 메모uspto-grants-1988_08